Patents
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
02/2014
02/12/2014CN102153488B Alpha,beta-diamino acid derivative, synthetic method thereof and application thereof
02/11/2014CA2559187C Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders
02/11/2014CA2501506C Modulation of anxiety through blockade of anandamide hydrolysis
02/11/2014CA2288330C Benzoyl amino acid derivatives useful as inhibitors of protein isoprenyl tranferases
02/06/2014WO2014021166A1 Method for producing blocked isocyanate compound
02/06/2014US20140039200 Organogold complexes and methods for making the same
02/05/2014CN103562182A Process for producing ester compound
02/05/2014CN103562178A Method of manufacturing isoxazoline compound
02/05/2014CN103553972A Method for the preparation of n-substituted carbamic acid ester and method for the preparation of isocyanate using the n-substituted carbamic acid ester
02/05/2014CN103553971A Preparation method for urethane acrylate
02/05/2014CN103553970A Preparation method of carbamate cationic lipid and application of carbamate cationic lipid in medicine or gene delivery
01/2014
01/30/2014WO2014018913A2 Santacruzamate a compositions and analogs and methods of use
01/30/2014US20140031331 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
01/28/2014US8637696 Methods for preparing amides and amino acids
01/28/2014US8637534 Fungicide active substance combinations
01/23/2014WO2014014606A1 Carbon dioxide capture and conversion to a carbamate salt and polyurea
01/23/2014WO2014014035A1 Pyrophosphoric acid ester compound, bisphosphoric acid ester compound, and catalyst
01/23/2014US20140024709 Methods of using cycloalkylmethylamine derivatives
01/22/2014EP2686297A2 Use of oligomeric carbodiimides as stabilizers
01/22/2014CN103524381A Synthesis of N-methylmethyl carbamate
01/17/2014CA2820192A1 Enzymatic synthesis process for (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, and application to the synthesis of ivabradine and of its salts
01/16/2014WO2014011220A2 A method of treating androgen receptor (ar)-positive breast cancers with selective androgen receptor modulator (sarms)
01/16/2014US20140018549 Use of d-serine derivatives for the treatment of anxiety disorders
01/16/2014US20140018433 Method of treating androgen receptor (ar) -positive breast cancers with selective androgen receptor modulator (sarms)
01/15/2014EP2684866A1 Compound and method for producing same, as well as method for producing oseltamivir phosphate
01/15/2014EP2684863A1 Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct
01/15/2014CN103508936A Intermediate for preparation of indole benzylamine compound
01/15/2014CN103508918A Cyclobutyl-containing alpha-hydroxy-beta-amino ester compound and preparation method thereof
01/14/2014US8629297 Low-foaming surfactants
01/09/2014WO2014007398A1 Cationic lipid
01/08/2014CN203382698U Methyl carbamate synthesis device
01/08/2014CN103497747A Well cementing slurry lightening agent and preparation method thereof
01/07/2014US8624053 Method to produce a stable dry ionic-bonded creatine α ketoglutarate of high oral absorbability
01/07/2014US8623913 Methods for treating restless legs syndrome
01/07/2014CA2721357C Process for producing isocyanates using diaryl carbonate
01/03/2014WO2014003203A2 Method for producing stereoselective epoxyketone compound
01/01/2014EP2679575A1 Process for producing carbonyl compounds
01/01/2014CN103492446A Novel compound, composition containing said compound, and cured product
01/01/2014CN103491928A Dental material, dental material composition, dental repair material, and cured product
01/01/2014CN103483342A Process for the synthesis of E1 activating enzyme inhibitors
01/01/2014CN103483236A Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentan0ic acid derivatives
01/01/2014CN103483226A Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
01/01/2014CN103483225A Preparation method for epoxy resin curing agent
01/01/2014CN103483224A Substituted urea alcoholysis method for synthesizing carbamate compounds
01/01/2014CN102600894B Method for preparing loaded organic acid zinc catalyst
12/2013
12/31/2013US8618124 Heterobifunctional polymeric bioconjugates
12/31/2013CA2552565C Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
12/31/2013CA2534298C Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same
12/27/2013WO2013191252A1 Novel polymerizable compound and method for producing same
12/26/2013US20130345423 Efficient peptide couplings and their use in the synthesis and isolation of a cyclopenta (g) quinazoline trisodium salt
12/26/2013US20130345386 Polyetheramine Macromonomers Comprising Two Neighboring Hydroxyl Groups And Their Use For Producing Polyurethanes
12/25/2013EP2675783A1 Addition-fragmentation agents
12/25/2013CN103467730A Carbamate compound
12/25/2013CN103467323A Method for preparing beta-unsaturated enamine ester derivative
12/25/2013CN103467225A Method for preparing 1,4-dicarbonyl derivative
12/25/2013CN102702461B Polyurethane with electrochromism performance and preparation method thereof
12/25/2013CN102557989B Ulimorelin intermediate and Ulimorelin preparation method
12/25/2013CN102026964B Process for producing isocyanate using diaryl carbonate
12/24/2013US8614346 Methods and compositions for preparation of amphetamine conjugates and salts thereof
12/19/2013WO2013187480A1 Novel cyclic depsipeptide derivative and pest control agent comprising same
12/19/2013WO2013185435A1 Optical activity axially chiral α-allenic alcohol, synthesis method and use thereof
12/19/2013CA2876387A1 Novel cyclic depsipeptide derivatives and harmful organism control agents comprising the same
12/18/2013CN101213199B Compounds for preparing immunological adjuvant
12/17/2013US8609882 Process for deacetalisation of α aminoacetals
12/17/2013US8609881 Cure accelerators for anaerobic curable compositions
12/17/2013US8609721 Ligands for metabotropic glutamate receptors and inhibitors of NAALADase
12/12/2013WO2013185116A1 Lipids for therapeutic agent delivery formulations
12/12/2013US20130331589 Chemical composition
12/12/2013US20130331568 Acetylene derivatives having mglur 5 antagonistic activity
12/12/2013CA2876148A1 Lipids for therapeutic agent delivery formulations
12/11/2013CN103435516A Modified tripentaerythritol acrylic ester with low viscosity, high reactivity and shrunk volume as well as preparation method thereof
12/11/2013CN103435515A Low-viscosity high-reactivity low-volume-shrinkage modified pentaerythritol acrylate and preparation method thereof
12/11/2013CN103435430A Method for reducing amide compounds
12/10/2013CA2552317C Hcv ns-3 serine protease inhibitors
12/05/2013WO2013180271A1 Prodrug of fluorine-containing amino acid
12/05/2013US20130324717 Copolymerizable methine and anthraquinone compounds and articles containing them
12/05/2013US20130324555 Method of use of pharmaceutical formulations for the treatment of apicomplexan diseases in animals
12/05/2013US20130324539 Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
12/05/2013CA2875080A1 Prodrug of fluorine-containing amino acid
12/04/2013EP2669265A2 Improved method for preparing dipeptidyl peptidase-IV inhibitor and intermediate
12/04/2013CN103420941A 2-methoxyphenyl-dimethylamino formic ether derivative and preparation method and application thereof
12/04/2013CN101553463B New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof
12/03/2013US8598297 Prepolymers made from hydroxymethyl-containing polyester polyols derived from fatty acids
12/03/2013CA2530302C Novel aminobenzophenone compounds
12/03/2013CA2489590C Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
11/2013
11/28/2013US20130317235 Process for the preparation of (1s, 3s, 5s)-2-[2(s)-2-amino-2-(3-hydroxy-1-adamantan-1-yl acetyl]-2-azabicyclo [3.1.0] hexane-3-carbonitrile
11/28/2013US20130317220 NOVEL PROCESSES FOR PREPARING TRIAZOLO[4, 5-d]PYRIMIDINE DERIVATIVES AND INTERMEDIATES THEREOF
11/28/2013US20130317007 Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at c-17
11/27/2013EP2666766A1 Novel E,E-diene compounds and their use as medicaments and cosmetics
11/27/2013EP2665702A1 Process for the preparation of retigabine
11/27/2013CN103415501A Iodoarene derivative, method for producing optically active spirolactone compound using same, and method for producing optically active cyclization adduct
11/27/2013CN103408465A N,N-disubstituted phenyl methyl valinamide carbamate derivant and application thereof
11/27/2013CN103408464A Low-viscosity high-reactivity low-volume-contraction modified dipentaerythritol acrylate and preparation method thereof
11/27/2013CN102659634B Synthetic method for 2-(N-4-fluorobenzyl) methoxy-acetyl-amino methyl isobutyrate
11/27/2013CN102553642B Catalyst and preparation method for sorafenib intermediate
11/27/2013CN102320993B Method for preparing (R)-2- Boc-amidogen-3-methoxypropionic acid
11/21/2013WO2013173779A1 Process for making amino acid compounds
11/21/2013WO2013172466A1 Method for forming negative pattern, method for producing electronic device, electronic device and actinic ray-sensitive or radiation-sensitive resin composition
11/21/2013WO2013171135A1 Lysin-glutamic acid dipeptide derivatives
11/20/2013EP2664374A1 Lysin-glutamic acid dipeptide derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 157